OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Epidemiology: Open Access received 3864 citations as per Google Scholar report
Articles published in Epidemiology: Open Access have been cited by esteemed scholars and scientists all around the world. Epidemiology: Open Access has got h-index 22, which means every article in Epidemiology: Open Access has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: Open Access.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
Journal total citations count | 3864 |
Journal impact factor | 10.58 |
Journal 5 years impact factor | 10.09 |
Journal cite score | 10.22 |
Journal h-index | 22 |
Journal h-index since 2019 | 18 |
![]() |
Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Additional risk minimisation measures in the EUâ are they eligible for assessment |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Communication on Safety of Medicines in Europe: Current Practices and General Practitionersâ Awareness and Preferences |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Methodological gaps in the assessment of risk minimization interventions: a systematic review |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Late Stage Complications of Diabetes and Insulin Resistance |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
The aetiology of vaginal symptoms in rural Haiti |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Malaria elimination in Haiti by the year 2020: an achievable goal? |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Prevalence of Obesity among Adult Surgical Patients in Tobago |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Exploring the role of obesity and overweight in predicting postoperative outcome of abdominal surgery in a sub-Saharan African setting: a prospective cohort study |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Coffea arabica: Herbal drug on Global health issue-obesity |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Prevalence of Obesity Among Thi-Qar University Students During the Year 2015- 2016 |
View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals